Methods of treating atopic dermatitis
US11964005B2 · kind B2 · utility
0Cited by
20References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2022 |
| Grant date | Apr 23, 2024 |
| Priority date | — |
| Expiry date | Mar 16, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to methods of treating atopic dermatitis comprising administering to a subject in need thereof a therapeutically effective amount of an anti-IL-13 antibody, or antigen binding fragment thereof, thereby treating atopic dermatitis in the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.